Web Summary
Q1: What is the address of LLPLS PHARMA's headquarters?
A1: The text does not explicitly mention the address of LLPLS PHARMA's headquarters, but it mentions that the HPRA (Health Products Regulatory Authority) has a presence in Dalkey Business Centre, 17 Castle Street, Dalkey, Co. Dublin, Ireland.
Q2: What types of medicines were detained by the HPRA in the first six months of 2022?
A2: The main categories of illegal products detained included sedatives (28%), anabolic steroids (12%), erectile dysfunction medicines (9%), and analgesics (7%).
Q3: How many dosage units of illegal medicines were detained by the HPRA between January and June 2022?
A3: Nearly half a million (486,088) dosage units of falsified and other illegal medicines were detained.
Q4: What is the name of the Director of Compliance with the HPRA who commented on the reduction in detentions?
A4: The Director of Compliance with the HPRA mentioned in the text is Grainne Power.
Q5: What is the purpose of the new digital information campaign launched by the HPRA to warn the public about the dangers of buying prescription medicines online?
A5: The campaign aims to increase public awareness and understanding of the safe supply routes for medicines and the associated dangers of buying prescription medicines online, with the goal of persuading people not to use this route.
Q6: How does the HPRA work in close co-operation with other agencies to combat the illegal supply of health products?
A6: The HPRA collaborates with An Garda Síochána (Irish police) and Revenue's Customs Service, as well as sharing intelligence with other regulatory and law enforcement agencies worldwide.
Q7: What is the contact information for reporting suspicious activities around the supply of medicines to the HPRA?
A7: The public can report suspicious activities to the HPRA at reportacase@hpra.ie or by phone at 01 634 3871.
Q8: How does the HPRA support prosecutions brought by the Director of Public Prosecutions in relation to the illegal supply of medicines?
A8: The HPRA supports prosecutions brought by the Director of Public Prosecutions, indicating a collaborative approach to addressing the issue of illegal medicine supply.